HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandra Cantilena Selected Research

Proto-Oncogene Proteins c-myb

1/2022Identification of a c-MYB-directed therapeutic for acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandra Cantilena Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 05/2012
5Neuroblastoma
01/2016 - 12/2011
1Leukemia
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Disease Progression
01/2022
1Glioma (Gliomas)
11/2021
1Alcoholism (Alcohol Abuse)
11/2021
1Carcinogenesis
03/2013
1Neoplasm Metastasis (Metastasis)
03/2013

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
11/2021 - 05/2012
1withaferin AIBA
01/2022
1LactonesIBA
01/2022
1Oncogene Proteins (Oncogene Protein)IBA
01/2022
1Proto-Oncogene Proteins c-mybIBA
01/2022
1Disulfiram (Antabuse)FDA Link
11/2021
1Proteins (Proteins, Gene)FDA Link
01/2016
1Polycomb Repressive Complex 2IBA
03/2013
1ChromatinIBA
03/2013
1polyphenon EIBA
03/2013
1TeaIBA
03/2013
1CamptothecinIBA
05/2012
1Irinotecan (Camptosar)FDA LinkGeneric
05/2012
1Topotecan (Hycamtin)FDA LinkGeneric
05/2012
1Transcription Factors (Transcription Factor)IBA
05/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2011
1Frizzled ReceptorsIBA
12/2011

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2022 - 01/2016
1Therapeutics
11/2021